Adenosine modulates cardiovascular functions through activation of extracellular signal-regulated kinases 1 and 2 and endothelial nitric oxide synthase in the nucleus tractus solitarii of rats

Circulation

Volumn 117, Issue 6, 2008, Pages 773-780

  Ho, Wen Yu ^a   Lu, Pei Jung ^c   Hsiao, Michael ^b   Hwang, Hwong Ru ^f   Tseng, Yu Chou ^c   Yen, Mao Hsiung ^a   Tseng, Ching Jiunn ^a,d,e,f  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b GENOMICS RESEARCH CENTER   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Adenosine; Baroreceptors; Brain; Nitric oxide; Signal transduction

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ADENOSINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; ENZYME ACTIVATION; HEART RATE; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRESSORECEPTOR; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SOLITARY TRACT NUCLEUS; WESTERN BLOTTING; ANIMAL; DRUG EFFECT; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADENOSINE; ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR PHYSIOLOGY; HEART RATE; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SOLITARY NUCLEUS;

EID: 39549092617     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.746032     Document Type: Article

References (44)

1. Tseng CJ, Biaggioni I, Appalsamy M, Robertson D. Purinergic receptors in the brainstem mediate hypotension and bradycardia. Hypertension. 1988;11:191-197.
2. Tseng CJ, Ger LP, Lin HC, Tung CS. Attenuated cardiovascular response to adenosine in the brain stem nuclei of spontaneously hypertensive rats. Hypertension. 1995;25:278-282.
3. Mosqueda-Garcia R, Tseng CJ, Appalsamy M, Robertson D. Cardiovascular effects of microinjection of angiotensin II in the brainstem of renal hypertensive rats. J Pharmacol Exp Ther. 1990;255:374-381.
4. Tseng CJ, Chou LL, Ger LP, Tung CS. Cardiovascular effects of angiotensin III in brainstem nuclei of normotensive and hypertensive rats. J Pharmacol Exp Ther. 1994;268:558-564.
5. Tseng CJ, Liu HY, Lin HC, Ger LP, Tung CS, Yen MH. Cardiovascular effects of nitric oxide in the brain stem nuclei of rats. Hypertension. 1996;27:36-42.
6. Lo WJ, Liu HW, Lin HC, Ger LP, Tung CS, Tseng CJ. Modulatory effects of nitric oxide on baroreflex activation in the brainstem nuclei of rats. Chin J Physiol. 1996;39:57-62.
7. Lo WC, Jan CR, Wu SN, Tseng CJ. Cardiovascular effects of nitric oxide and adenosine in the nucleus tractus solitarii of rats. Hypertension. 1998;32:1034-1038.
8. Lin CH, Lo WC, Hsiao M, Tseng CJ. Interaction of carbon monoxide and adenosine in the nucleus tractus solitarii of rats. Hypertension. 2003;42:380-385.
9. Lin CH, Lo WC, Hsiao M, Tung CS, Tseng CJ. Interactions of carbon monoxide and metabotropic glutamate receptor groups in the nucleus tractus solitarii of rats. J Pharmacol Exp Ther. 2004;308:1213-1218.
10. Lo WC, Hsiao M, Tung CS, Tseng CJ. The cardiovascular effects of nitric oxide and carbon monoxide in the nucleus tractus solitarii of rats. J Hypertens. 2004;22:1182-1190.
11. Lo WC, Lu PJ, Ho WY, Hsiao M, Tseng CJ. Induction of heme oxygenase-1 is involved in carbon monoxide-mediated central cardiovascular regulation. J Pharmacol Exp Ther. 2006;318:8-16.
12. Huang HN, Lu PJ, Lo WC, Lin CH, Hsiao M, Tseng CJ. In situ Akt phosphorylation in the nucleus tractus solitarii is involved in central control of blood pressure and heart rate. Circulation. 2004;110:2476-2483.
13. Scislo TJ, O'Leary DS. Purinergic mechanisms of the nucleus of the solitary tract and neural cardiovascular control. Neurol Res. 2005;27:182-194.
14. Phillis JW, Scislo TJ, O'Leary DS. Purines and the nucleus tractus solitarius: effects on cardiovascular and respiratory function. Clin Exp Pharmacol Physiol. 1997;24:738-742.
15. Barraco RA, Phillis JW. Subtypes of adenosine receptors in the brainstem mediate opposite blood pressure responses. Neuropharmacology. 1991;30:403-407.
16. Mosqueda-Garcia R, Tseng CJ, Appalsamy M, Robertson D. Modulatory effects of adenosine on baroreflex activation in the brainstem of normotensive rats. Eur J Pharmacol. 1989;174:119-122.
17. Dunwiddie TV, Masino SA. The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci. 2001;24:31-55.
18. Scislo TJ, O'Leary DS. Activation of A2a adenosine receptors in the nucleus tractus solitarius inhibits renal but not lumbar sympathetic nerve activity. J Auton Nerv Syst. 1998;68:145-152.
19. Scislo TJ, O'Leary DS. Mechanisms mediating regional sympathoactivatory responses to stimulation of NTS A(1) adenosine receptors. Am J Physiol. 2002;283:H1588-H1599.
20. Ribeiro JA, Sebastiao AM, de Mendonca A. Adenosine receptors in the nervous system: pathophysiological implications. Prog Neurobiol. 2002;68:377-392.
21. Scislo TJ, Tan N, O'Leary DS. Differential role of nitric oxide in regional sympathetic responses to stimulation of NTS A2a adenosine receptors. Am J Physiol. 2005;288:H638-H649.
22. Sobrevia L, Yudilevich DL, Mann GE. Activation of A2-purinoceptors by adenosine stimulates L-arginine transport (system y+) and nitric oxide synthesis in human fetal endothelial cells. J Physiol. 1997;499:135-140.
23. Li J, Fenton RA, Wheeler HB, Powell CC, Peyton BD, Cutler BS, Dobson JG Jr. Adenosine A2a receptors increase arterial endothelial cell nitric oxide. J Surg Res. 1998;80:357-364.
24. Wyatt AW, Steinert JR, Wheeler-Jones CP, Morgan AJ, Sugden D, Pearson JD, Sobrevia L, Mann GE. Early activation of the p42/p44MAPK pathway mediates adenosine-induced nitric oxide production in human endothelial cells: a novel calcium-insensitive mechanism. FASEB J. 2002;16:1584-1594.
25. Sweatt JD. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem. 2001;76:1-10.
26. Thomas GM, Huganir RL. MAPK cascade signalling and synaptic plasticity. Nat Rev. 2004;5:173-183.
27. Berman DE, Hazvi S, Neduva V, Dudai Y. The role of identified neurotransmitter systems in the response of insular cortex to unfamiliar taste: activation of ERK1-2 and formation of a memory trace. J Neurosci. 2000;20:7017-7023.
28. Schafe GE, Atkins CM, Swank MW, Bauer EP, Sweatt JD, LeDoux JE. Activation of ERK/MAP kinase in the amygdala is required for memory consolidation of pavlovian fear conditioning. J Neurosci. 2000;20:8177-8187.
29. Dai Y, Iwata K, Fukuoka T, Kondo E, Tokunaga A, Yamanaka H, Tachibana T, Liu Y, Noguchi K. Phosphorylation of extracellular signal-regulated kinase in primary afferent neurons by noxious stimuli and its involvement in peripheral sensitization. J Neurosci. 2002;22:7737-7745.
30. Sutton GM, Patterson LM, Berthoud HR. Extracellular signal-regulated kinase 1/2 signaling pathway in solitary nucleus mediates cholecystokinin- induced suppression of food intake in rats. J Neurosci. 2004;24:10240-10247.
31. Springell DA, Costin NS, Pilowsky PM, Goodchild AK. Hypotension and short-term anaesthesia induce ERK1/2 phosphorylation in autonomic nuclei of the brainstem. Eur J Neurosci. 2005;22:2257-2270.
32. Roberson ED, English JD, Adams JP, Selcher JC, Kondratick C, Sweatt JD. The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus. J Neurosci. 1999;19:4337-4348.
33. Stork PJ, Schmitt JM. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. 2002;12:258-266.
34. Vossler MR, Yao H, York RD, Pan MG, Rim CS, Stork PJ. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell. 1997;89:73-82.
35. Dugan LL, Kim JS, Zhang Y, Bart RD, Sun Y, Holtzman DM, Gutmann DH. Differential effects of cAMP in neurons and astrocytes: role of B-raf. J Biol Chem. 1999;274:25842-25848.
36. Dumaz N, Marais R. Integrating signals between cAMP and the RAS/ RAF/MEK/ERK signalling pathways: based on the anniversary prize of the Gesellschaft für Biochemie und Molekularbiologie Lecture delivered on 5 July 2003 at the Special FEBS Meeting in Brussels. FEBS J. 2005;272:3491-3504.
37. Morice C, Nothias F, Konig S, Vernier P, Baccarini M, Vincent JD, Barnier JV. Raf-1 and B-Raf proteins have similar regional distributions but differential subcellular localization in adult rat brain. Eur J Neurosci. 1999;11:1995-2006.
38. Cale JM, Bird IM. Inhibition of MEK/ERK1/2 signalling alters endothelial nitric oxide synthase activity in an agonist-dependent manner. Biochem J. 2006;398:279-288.
39. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest. 1999;103:401-406.
40. Chen DB, Bird IM, Zheng J, Magness RR. Membrane estrogen receptor-dependent extracellular signal-regulated kinase pathway mediates acute activation of endothelial nitric oxide synthase by estrogen in uterine artery endothelial cells. Endocrinology. 2004;145:113-125.
41. Feliers D, Chen X, Akis N, Choudhury GG, Madaio M, Kasinath BS. VEGF regulation of endothelial nitric oxide synthase in glomerular endothelial cells. Kidney Int. 2005;68:1648-1659.
42. Waki H, Murphy D, Yao ST, Kasparov S, Paton JF. Endothelial NO synthase activity in nucleus tractus solitarii contributes to hypertension in spontaneously hypertensive rats. Hypertension. 2006;48:644-650.
43. Waki H, Kasparov S, Wong LF, Murphy D, Shimizu T, Paton JF. Chronic inhibition of endothelial nitric oxide synthase activity in nucleus tractus solitarii enhances baroreceptor reflex in conscious rats. J Physiol. 2003;546:233-242.
44. Handy RL, Harb HL, Wallace P, Gaffen Z, Whitehead KJ, Moore PK. Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects. Br J Pharmacol. 1996;119:423-431.